Epsilon-3 Bio

Scroll
Investment area
Novo Ventures
Region
Europe
Date of investment
December 2011
Website
http://www.epsilon-3.com/

Epsilon-3 Bio develops compounds targeting the removal of cellular debris in chronic inflammatory and autoimmune disorders. The lead compound is in pre-clinical development.